Ondek Pty Ltd is an Australian biotechnology company that specializes in developing a groundbreaking drug delivery platform called the Helicobacter pylori Platform Technology (HPPT). This innovative platform harnesses the unique characteristics of the Helicobacter pylori bacterium to deliver a wide range of therapeutics, including immune modulators, biopharmaceuticals, drugs, and vaccines.
Founded by Nobel Laureate Professor Barry Marshall, Ondek is led by a world authority and co-discoverer of the Helicobacter pylori organism, who was also a co-recipient of the 2005 Nobel Prize for Medicine and Physiology. With a focus on biological delivery systems, Ondek is at the forefront of biotechnology advancements, aiming to revolutionize drug delivery and improve patient outcomes.
Generated from the website